20158 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate; Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals; Wall or coating material; Compounds of unknown constitution, e.g. material from plants or animals Cell membranes or bacterial membranes enclosing drugs
Engineered Umbilical Cord Mesenchymal Stem Cell Exosomes Loaded with siCCR5 for Treating Alzheimer's Disease
#2CELL-DERIVED MICROPARTICLE DELIVERY SYSTEM AND USES THEREOF
#3MICROPARTICLE, PREVENTIVE DRUG OR THERAPEUTIC DRUG FOR ERECTILE DYSFUNCTION, AND METHOD FOR IMPROVING ERECTILE DYSFUNCTION
#4APPLICATION OF BCG-BASED OMV TRAINED IMMUNITY INDUCER IN PREPARATION OF IMMUNOTHERAPEUTIC DRUG FOR SEPSIS
#5METHOD FOR PREPARING EXOSOME AND USE OF EXOSOME PREPARED THEREBY
#6ANTI-INFLAMMATORY RED BLOOD CELL EXTRACELLULAR VESICLES (RBCEVS)
#7COMPOSITION AND METHODS TO REDUCE INFLAMMATION AND PROMOTE REJUVENATION
#8METHOD OF PRODUCING ENGINEERED EXOSOME-MIMETIC VESICLES
#9OGA-OVEREXPRESSED EXOSOME SYSTEM, PREPARATION METHOD THEREFOR AND USE THEREOF
#10USE OF MONOLITHIC ANION EXCHANGE CHROMATOGRAPHY AND LIGHT SCATTERING FOR QUANTIFYING EXTRACELLULAR VESICLES
#11PLATFORMS, COMPOSITIONS, AND METHODS FOR THERAPEUTIC DELIVERY
#12PROTEIN OR POLYPEPTIDE-LOADED EXTRACELLULAR VESICLE DELIVERY PLATFORM AND APPLICATION THEREOF
#13COMPOSITIONS COMPRISING WATER INSOLUBLE DRUGS AND METHODS OF PRODUCING AND USING SAME
#14COMPOSITIONS AND METHODS RELATED TO MEGAKARYOCYTE-DERIVED EXTRACELLULAR VESICLES FOR FANCONI ANEMIA
#15METHOD FOR LOADING DIMERIC CD24 INTO HEK293 CELL EXTRACELLULAR VESICLES WITH ADAM10 GENE KNOCKED OUT
#16METHODS AND USE FOR BIOENGINEERING ENUCLEATED CELLS
#17Systems and Methods of Exosome Mediated Delivery of Antibodies
#18ADJUVANTED IMMUNOGENIC COMPOSITION AGAINST NEISSERIA MENINGITIDIS B
#19LOADED EXTRACELLULAR VESICLE
#20COATED NANOPARTICLES FOR THE TREATMENT OF PERIPHERAL ARTERY DISEASE
#21ARTIFICIAL INTELLIGENCE-GUIDED PROTEIN DESIGN FOR NANOVESICLE ANALYSIS AND ENGINEERING
#22MANUFACTURING SYSTEMS AND METHODS FOR CELLULAR THERAPEUTIC PLATFORMS
#23CONSTRUCTION OF ENGINEERED EXTRACELLULAR VESICLE AND USE THEREOF
#24COMPOSITIONS FOR HYPERVESICULATING GUT MICROBES AND THERAPEUTIC ENZYME DELIVERY AND METHODS OF USE THEREOF
#25METHOD FOR CONSTRUCTING GRAM-NEGATIVE BACTERIAL OUTER MEMBRANE-DERIVED NANOVESICLES AND USE THEREOF
#26METHODS OF MAKING AND USING IMMUNE-TOLERIZED FETAL STEM CELL-DERIVED EXTRACELLULAR VESICLES FOR HAIR LOSS TREATMENT
#27ANTICANCER COMPOSITION COMPRISING STEM CELL-DERIVED EXOSOMES AND PREPARATION METHOD THEREFOR
#28CELL-DERIVED VESICLES ENGINEERED WITH ANCHOR PROTEINS AND USE THEREOF
#29METHOD FOR PRODUCING EXTRACELLULAR VESICLES CONTAINING BIOACTIVE SUBSTANCE
#30RNA INTERFERENCE OLIGONUCLEOTIDES FOR INHIBITING PERINEURONAL NETWORK FORMATION
#31MAKING PROGRAMMED CELL-DERIVED VESICLES
#32METHODS FOR MANUFACTURING AND USING EXTRACELLULAR VESICLES
#33HMGB1 EXPRESSION REGULATOR, PROPHYLACTIC AGENT OR THERAPEUTIC AGENT FOR ACUTE LUNG INJURY, ACUTE RESPIRATORY DISTRESS SYNDROME, OR SEPSIS, OR METHOD OF AMELIORATING SAME
#34METHODS OF USING EXTRACELLULAR VESICLE-ASO TARGETING STAT6
#35NANOPARTICLES CONTAINING CELLULAR MEMBRANE AND USES THEREOF
#36MACROPHAGE-DERIVED ENGINEERED VESICLES FOR TARGETED DELIVERY AND TREATMENT
#37EXTRACELLULAR VESICLE COMPRISING ANTIGENIC PROTEIN OR GENE ENCODING SAME PROTEIN, AND USES THEREOF
#38CONTROLLED EXPRESSION OF THERAPEUTICALLY RELEVANT BIOMOLECULES FOR LUMEN-LOCALIZED PAYLOADS IN BIOMIMETIC NANOVESICLES AND EXOSOMES
#39METHODS FOR IMPROVING BONE HEALTH WITH BOVINE MILK EXOSOME-ENRICHED PRODUCTS AND VITAMIN K2
#40ACTIVE LOADING OF CARGO ENTITY INTO LIPID BILAYER PARTICLES USING DIMERIZATION DOMAINS
#41ALLOGENEIC EXTRACELLULAR VESICLES FOR CANCER TREATMENT
#42METHODS FOR EVALUATION OF EXTRACELLULAR VESICLES
#43EXTRACELLULAR VESICLES FUNCTIONALIZED WITH AN ERV SYNCITIN AND USES THEREOF FOR CARGO DELIVERY
#44EXTRACELLULAR VESICLES DERIVED FROM MILK AND PROCESS FOR ISOLATING THE SAME
#45AGASTACHE RUGOSA EXOSOMES COMPOSITION FOR ENHANCING SKIN BARRIER AND ANTI-INFLAMMATION AND METHOD THEREOF
#46COMPOSITION FOR WOUND TREATMENT COMPRISING STEM CELL-DERIVED EXTRACELLULAR VESICLES WITH ENHANCED EFFICACY
#47EXOSOMES EXPRESSING RSVF AND USE THEREOF
#48COMPOSITION AND METHOD FOR TREATING LUNG DISEASES
#49COMPOSITION FOR PROMOTING ANGIOGENESIS COMPRISING EXTRACELLULAR VESICLES DERIVED FROM THREE-DIMENSIONAL SPHEROID-TYPE CELL AGGREGATE
#50EXOSOME THERAPY AND PROCESS TO IMPROVE FORMULATION AND PRODUCTION
#51PROCESS FOR THE PREPARATION OF ERYTHROCYTES LOADED WITH ONE OR MORE SUBSTANCES OF PHARMACEUTICAL INTEREST AND SO OBTAINED ERYTHROCYTES
#52COMPOSITIONS AND METHODS RELATED TO EXTRACELLULAR VESICLE THERAPEUTIC DELIVERY PLATFORM
#53EXOSOMAL COMPOSITIONS INCLUDING ANESTHETICS
#54MRNA EXPRESSION AND DELIVERY SYSTEMS
#55METHOD OF GENE TARGETING UTILIZING OUTER MEMBRANE VESICLE
#56MATRIX BOUND NANOVESICLES ENCAPSULATED IN HYDROGELS
#57BIOLOGICAL MATERIAL FOR DELIVERING SPECIFIC CELL-TARGETED METABOLIC SYSTEM, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#58METHOD FOR PRODUCING DELIVERY VESICLES
#59METHOD OF ISOLATING A HIGH NUMBER OF EXOSOME EXTRACTS WITH HIGH-ACTIVITY FROM ANIMAL-DERIVED CORD BLOOD OR FETAL ANIMAL OR ANIMAL MILK OR OTHER ANIMAL-DERIVED BODY FLUIDS TO ALLOW HIGH-ACTIVITY EXOSOME-LIPOSOME HYBRIDIZATION
#60NEPHRON PROGENITOR EXOSOMES
#61DENTAL PULP AND DENTIN REGENERATION
#62THERAPEUTIC VESICLES AND METHODS OF PROCESSING THE SAME
#63FPR2 AGONIST CONTAINING OUTER MEMBRANE VESICLES DERIVED FROM LACTIC ACID BACTERIUM
#64ENGINEERED EXTRACELLULAR VESICLES FOR TARGETED DRUG DELIVERY TO MUSCLE
#65USE OF A PURIFIED EXOSOME DRY POWDER FOR RELIEVING INFLAMMATION OR INJURY
#66EXTRACELLULAR VESICLES DERIVED FROM OSTEOBLAST LINEAGE CELLS FOR THERAPEUTIC AND DIAGNOSTIC USE
#67TISSUE AND CELL-TYPE SPECIFIC DELIVERY OF THERAPEUTIC MOLECULES INCORPORATING VIRAL AND HUMAN FUSIOGENIC PROTEINS
#68LOTUS LEAF-DERIVED EXOSOMES HAVING DISPERSION STABILITY AND USE THEREOF IN ALLEVIATING INFLAMMATORY RESPONSE OR IN WOUND HEALING
#69TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS
#70NASAL ANTI-CANCER THERAPIES
#71METHODS AND COMPOSITIONS FOR TREATING DIABETES
#72MODIFIED EXTRACELLULAR VESICLES THAT SPECIFICALLY TARGET KIDNEYS AND METHODS OF PREPARATION AND APPLICATIONS THEREOF
#73METHODS OF LOADING EXTRACELLULAR VESICLES
#74SMALL EXTRACELLULAR VESICLES EXPRESSING A DOMINANT NEGATIVE AMPK ALPHA 1 MUTANT FOR USE IN THE TREATMENT OF OBESITY
#75APPLICATION OF BMSC-EXOS IN TREATING PD
#76ENGINEERED MIGRASOME, METHOD FOR PREPARING SAME, AND USES THEREOF
#77EGF-RICH EXOSOMES, PREPARATION METHOD AND USE THEREOF
#78TARGETED EXTRACELLULAR VESICLES FOR DELIVERY OF THERAPEUTICS
#79ORGANIC-INORGANIC REACTIVE SCINTILLATORS FOR USE IN DISEASE TREATMENT
#80Compositions and Methods for Treating Cancer
#81COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING INFLAMMATORY DISEASES COMPRISING EXTRACELLULAR VESICLES DERIVED FROM ROSEBURIA SPP. OR BIFIDOBACTERIUM SPP.
#82GENETICALLY ENGINEERED MULTIFUNCTIONAL EXOSOMES FOR IMMUNOTHERAPY
#83LIGHT-INDUCED CELLULAR PRODUCTION OF IMMUNE FUNCTIONAL EXTRACELLULAR VESICLES
#84PRODUCT CONTAINING PLANT DERIVED EXTRACELULAR VESICLES TO HELP SLIMMING AND REDUCES THE APPEARANCE OF CELLULITE
#85CXCL14-BASED COMPOSITIONS AND METHOD FOR ENHANCING CARTILAGE REGENERATION
#86PLATELET-DERIVED EXTRACELLULAR VESSICLES FOR TREATMENT OF CARDIOGENIC SHOCK AND SEPSIS
#87EXOSOME, METHOD OF FORMING SAME, AND COMPOSITION CONTAINING SAME
#88COMPOSITION COMPRISING HYBRID EXOSOME
#89DIRECT PRODUCTION OF SIRNAS IN SACCHAROMYCES BOULARDII AND PACKAGING IN EXTRACELLULAR VESICLES (EVs) FOR TARGETED GENE SILENCING
#90COMPOSITIONS AND METHODS FOR WOUND HEALING
#91EXOSOME COMPOSITION CONTAINING GANODERMA IMMUNOMODULATORY PROTEIN AND USES THEREOF
#92FUNCTIONALIZED BIOLOGICAL MEMBRANES WITH MODIFYING PROTEIN MOLECULES, AND METHODS OF MAKING AND USES THEREOF
#93NEURAL CELL EXTRACELLULAR VESICLES
#94Engineered Exosome for Treating Hypertrophic Scar (Hts), and Preparation Method and Use Thereof
#95DELTA PROTOCADHERIN THERAPIES
#96DESIGNER EXTRACELLULAR VESICLES FOR TARGETED DELIVERY TO SCHWANN CELLS
#97circCDK13-ENRICHED ENGINEERED SMALL EXTRACELLULAR VESICLE (E-sEV), AND PREPARATION METHOD AND USE THEREOF
#98EFFICIENT HIGH-THROUGHPUT ELECTROPORATION FOR EV AND EXOSOME CARGO LOADING
#99COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING LIVER FIBROSIS
#100PREVOTELLA EXTRACELLULAR VESICLE PREPARATIONS
#101AN ANTI-INFLAMMATORY COMPOSITION AND A METHOD OF OBTAINING THE SAME
#102METHODS OF USE AND ADMINISTRATION OF ENCAPSULATED CELLS
#103Neuronal diencephalon stem cells and exosomes thereof for the treatment and prevention of diseases
#104METHODS OF CELL CULTURE FOR ADOPTIVE CELL THERAPY
#105Loading of Extracellular Signaling Molecules Into Lipid-Bound Vesicles for Therapeutic Applications
#106ECTOSOME-BIODEGRADABLE POLYMER NANOPARTICLE COMPLEX WITH ENHANCED TARGETING TO LESIONS AND ITS METHOD OF PREPARATION
#107PLASMID PLATFORM FOR STABLE EXPRESSION AND DELIVERY OF BIOMOLECULES
#108POLYMERIC MICELLE NANOPARTICLES FOR ON-DEMAND CELLULAR PACKAGING OF EXTRACELLULAR VESICLES
#109TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS
#110ORAL ROOM-TEMPERATURE STABLE YEAST PARTICLES (YP) AND METHODS OF USE
#111NANOCOMPOSITE AND PREPARATION METHOD AND USE THEREOF
#112METHOD FOR SURFACE EXPRESSION OF MEMBRANE PROTEINS THAT HAVE A CYTOPLASMIC C-TERMINAL TAIL
#113NOVEL COMPOSITION COMPRISING NEPETA CATARIA-DERIVED EXOSOMES AS ACTIVE INGREDIENT
#114MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE
#115EXTRACELLULAR VESICLES FOR INHALATION
#116MESENCHYMAL STEM CELL-DERIVED EXOSOME DRUG DELIVERY FOR CANCER AND OTHER DISORDERS
#117TAILORED HYPOIMMUNENANOVESICULAR DELIVERY SYSTEMS FOR CANCER TUMORE, HEREDITARY AND INFECTIOUS DISEASES
#118NANOVESICLES DERIVED FROM CELL MEMBRANE, AND USE THEREOF
#119Methods for the Treatment of Cancer, Inflammatory Diseases and Autoimmune Diseases
#120EXTRACELLULAR VESICLE-ENRICHED SECRETOME COMPOSITION DERIVED FROM INDUCED PLURIPOTENT STEM CELL DERIVED-MICROGLIA AND METHODS OF USE THEREOF
#121COMPOSITIONS COMPRISING EXTRACELLULAR VESICLES AND AN ACTIVE AGENT AND USES THEREOF
#122PRODUCTION OF THERAPEUTIC MESENCHYMAL STEM CELL-DERIVED EXOSOMES
#123COMPOSITIONS AND METHODS RELATED TO MEGAKARYOCYTE-DERIVED EXTRACELLULAR VESICLES FOR FANCONI ANEMIA
#124UMBILICAL CORD MESENCHYMAL CELL EXTRACELLULAR VESICLES FOR THE TREATMENT OF OSTEOARTICULAR AND AUTOIMMUNE DISEASES
#125Allogeneic Cartilage Regeneration
#126NANOPARTICLES SEQUENTIALLY EXPOSED TO LOW INTENSITY ACOUSTIC WAVES FOR MEDICAL OR COSMETIC APPLICATIONS
#127SYSTEMS AND METHODS FOR EXOSOME DELIVERY OF MICRORNAS FOR CELLULAR REPROGRAMMING
#128NANOCARRIERS FOR TARGETING TUMOR ASSOCIATED MACROPHAGES
#129EXTRACELLULAR VESICLES FROM MICROALGAE, THEIR PREPARATION, AND USES
#130Targeted extracellular vesicles for delivery of therapeutics
#131RNA PLASMID DELIVERY SYSTEM AND APPLICATION THEREOF
#132Treatment of von Willebrand disease
#133EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF
#134MIRNA COMPOSITION COMPRISING 11 SPECIFIC MIRNAS AND ITS USE IN THE TREATMENT OF CANCER
#135DELIVERY OF THERAPEUTIC RNAS VIA ARRDC1-MEDIATED MICROVESICLES
#136NANO-SILICA - IN YEAST PARTICLE (YP) DRUG ENCAPSULATION APPROACH FOR IMPROVED THERMAL AND HYDROLASE STABILITY OF YP DRUG DELIVERY FORMULATIONS
#137COMPOSITIONS FOR FACILITATING MEMBRANE FUSION AND USES THEREOF
#138METHODS OF CELL CULTURE FOR ADOPTIVE CELL THERAPY
#139COMPOSITIONS OF ENGINEERED EXOSOMES AND METHODS OF LOADING LUMINAL EXOSOMES PAY-LOADS
#140Intradermal Delivery of Extracellular Vesicle-Encapsulated Curcumin Using Dissolvable Microneedle Arrays
#141METHODS OF CELL CULTURE FOR ADOPTIVE CELL THERAPY
#142PREPARATION METHOD AND APPLICATION OF TUMOR MICROPARTICLES ENCAPSULATING METABOLIC INHIBITORS
#143IMMUNOENGINEERING BIOMATERIALS FOR TREATMENT OF GRAFT REJECTION
#144METHODS AND COMPOSITIONS FOR MACROPHAGE POLARIZATION
#145ENGINEERED EXTRACELLULAR VESICLES DISPLAYING ENHANCED PHARMACOKINETICS
#146VESICLES COMPRISING A PTEN INHIBITOR AND USES OF SAME
#147NANOPARTICLE FOR THE REMODELING OF CANCER-ASSOCIATED FIBROBLASTS
#148EXTRACELLULAR VESICLES WITH IMPROVED HALF-LIFE
#149ARTIFICIAL ANTIGEN PRESENTING CELL SYSTEM AND USES THEREOF
#150STIMULATING CELLULAR PRODUCTION OF EXOSOMES
#151COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS USING OSCILLOSPIRACEAE MICROBIAL EXTRACELLULAR VESICLES
#152ARRDC1-MEDIATED MICROVESICLE-BASED DELIVERY TO THE NERVOUS SYSTEM
#153SODIUM BUTYRATE FOR USE IN THE PREVENTION OR TREATMENT OF RHINOVIRUS INFECTION
#154DEXAMETHASONE-LOADED MACROPHAGE-DERIVED MICROVESICLE AS WELL AS PREPARATION METHOD AND APPLICATION THEREOF
#155TUMOR VACCINE, PREPARATION METHOD THEREFOR AND USE THEREOF
#156FACTOR B INHIBITORS AND USES THEREOF
#157Compositions and methods related to megakaryocyte-derived extracellular vesicles
#158TAILORED HYPOIMMUNE NANOVESICULAR DELIVERY SYSTEMS FOR CANCER TUMORS, HEREDITARY AND INFECTIOUS DISEASES
#159STEM CELL BIOMIMETIC NANOPARTICLE THERAPEUTIC AGENTS AND USES THEREOF
#160RED BLOOD CELL-DERIVED VESICLE
#161MESENCHYMAL STROMAL CELLS AND EXTRACELLULAR VESICLES FOR TREATING VIRAL INFECTIONS, INFLAMMATION, AND TISSUE FIBROSIS
#162METHODS AND USE FOR BIOENGINEERING ENUCLEATED CELLS
#163EXOSOME-DELIVERED TARGETING TREATMENT FOR BLOOD VESSELS
#164MACROPHAGE-DERIVED ENGINEERED VESICLES FOR TARGETED DELIVERY AND TREATMENT
#165COMPOSITIONS AND METHODS FOR ENHANCED UPTAKE OF ACTIVE INGREDIENTS FOR ANIMAL HEALTH AND NUTRITION
#166THERAPEUTIC COMPOSITIONS CONTAINING BACTERIAL OUTER MEMBRANE VESICLES AND USES THEREOF
#167STING AGONIST COMPRISING EXOSOMES COMBINED WITH IL-12 DISPLAYING EXOSOMES FOR TREATING A TUMOUR
#168Platforms, compositions, and methods for therapeutic delivery
#169Hybrid membrane camouflaged nanomedicine loaded with oxidative phosphorylation inhibitor and preparing method thereof
#170NANOPARTICLES CONTAINING CELLULAR MEMBRANE AND USES THEREOF
#171Neural cell extracellular vesicles
#172PROCESS OF MAKING MEMBRANE LIPID COATED NANOPARTICLES
#173MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE
#174Exosome-Mediated Transfection for Delivery of Nucleic Acids
#175DIAGNOSTIC AND THERAPEUTIC USES OF COMPOSITIONS COMPRISING PURIFIED, ENRICHED POTENT EXOSOMES CONTAINING DISEASE-BASED AND THERAPY BASED SIGNATURE CARGO
#176LARGE SCALE PRODUCTION OF EXOSOME MIMETICS AND USES THEREOF
#177Efficient delivery of therapeutic molecules to cells of the inner ear
#178Membrane lipid coated nanoparticles and method of use
#179CAPSID THERAPY
#180DRUG DELIVERY COMPOSITION
#181EXOSOME COMPRISING STABILIZED RNA THERAPEUTICS
#182TAILORED HYPOIMMUNE NANOVESICULAR DELIVERY SYSTEMS FOR CANCER TUMORS
#183EXTRACELLULAR VESICLES FOR DELIVERING THERAPEUTIC OR DIAGNOSTIC DRUGS
#184CELL PENETRATING PEPTIDE (CPP)-MEDIATED EV LOADING
#185BIOMIMETIC ANISOTROPIC POLYMERIC PARTICLES WITH NATURALLY DERIVED CELL MEMBRANES FOR ENHANCED DRUG DELIVERY
#186Tumoricidal and antimicrobial compositions and methods
#187Tumoricidal and antimicrobial compositions and methods
#188Vaccine delivery systems using yeast cell wall particles
#189PLATFORMS, COMPOSITIONS, AND METHODS FOR THERAPEUTIC DELIVERY
#190Dynamic bio-nanoparticle platforms
#191PHARMACEUTICAL COMPOSITIONS AND DELIVERY SYSTEMS FOR PREVENTION AND TREATMENT OF CANDIDIASIS
#192METHODS AND COMPOSITIONS RELATED TO EXTRACELLULAR VESICLES
#193EXTRACELLULAR VESICLES COMPRISING STING-AGONIST
#194Treatment of von Willebrand disease
#195Extracellular vesicles for inhalation
#196ANTI-FIBRINOLYTIC LOADED PLATELETS
#197METHODS OF SUPPRESSING DELIVERY OF EXOSOMES TO LIVER AND SPLEEN
#198Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
#199Delivery of therapeutic RNAs via ARRDC1-mediated microvesicles
#200Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
#201Membrane lipid coated nanoparticles and method of use
#202Nanovesicles derived from cell membrane, and use thereof
#203Methods and compositions for T cell activation
#204COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY
#205BIOMOLECULAR COMPOSITES COMPRISING MODIFIED CELL GHOSTS
#206Vesicles comprising a PTEN inhibitor and uses of same
#207BIOXOMES PARTICLES, REDOXOMES, METHOD AND COMPOSITION
#208YEAST CELL WALL PARTICLE ENCAPSULATION OF BIODEGRADABLE PRO-PAYLOADS
#209Engineered B lymphocytes and compositions having micro-RNA and methods for making and using them
#210Pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor
#211ENGINEERED NANOVESICLES AS CHECKPOINT BLOCKADE FOR CANCER IMMUNOTHERAPY
#212Methods and compositions for macrophage polarization
#213Protein engineered extracellular vesicles
#214Vaccine delivery systems using yeast cell wall particles
#215Method for producing exosomes and exosomes obtained thereby
#216COMPOSITIONS OF ENGINEERED EXOSOMES AND METHODS OF LOADING LUMINAL EXOSOMES PAY-LOADS
#217METHODS AND COMPOSITIONS FOR TREATING CANCER USING EXOSOMES-ASSOCIATED GENE EDITING
#218TARGETED AND MODULAR EXOSOME LOADING SYSTEM
#219BIOMIMETIC ANISOTROPIC POLYMERIC PARTICLES WITH NATURALLY DERIVED CELL MEMBRANES FOR ENHANCED DRUG DELIVERY
#220Oncolytic herpes simplex virus infected cells
#221Hydrogel toxin-absorbing or binding nanoparticles
#222COMPOSITIONS CONTAINING A HOLLOW GLUCAN PARTICLE OR A CELL WALL PARTICLE ENCAPSULATING A TERPENE COMPONENT, METHODS OF MAKING AND USING THEM
#223PLATELETS AS DELIVERY AGENTS
#224Detoxification using nanoparticles
#225Platelets loaded with anti-cancer agents
#226INSTANT THICKENED DRY FOOD COMPOSITIONS
#227ANALYSIS OF GENOMIC DNA, RNA, AND PROTEINS IN EXOSOMES FOR DIAGNOSIS AND THERANOSIS
#228EXTRACELLULAR VESICLES FOR AGENT DELIVERY
#229Functionalized Prussian blue nanoparticles, combination Prussian blue nanoparticle-based nano-immunotherapy and applications thereof
#230FORMULATION COMPRISING EXTRACELLULAR VESICLES, METHOD FOR PRODUCING THE SAME, AND USES THEREOF
#231Compositions and methods for loading extracellular vesicles with chemical and biological agents/molecules
#232Bacterial membrane nanoparticles as an immunotherapy system for cancer treatment
#233Vaccine delivery systems using yeast cell wall particles
#234Compositions for facilitating membrane fusion and uses thereof
#235Membrane lipid coated viral nanoparticles and method of use
#236Tumoricidal and antimicrobial compositions and methods
#237Stem cell biomimetic microparticles
#238ERYTHROID CELLS COMPRISING PHENYLALANINE HYDROXYLASE
#239Cell penetrating peptide (CPP)-mediated EV loading
#240PLATELETS COMPRISING EXOGENOUS POLYPEPTIDES AND USES THEREOF
#241Coated edible plant-derived microvesicle compositions and methods for using the same
#242Modulating antibacterial immunity via bacterial membrane-coated nanoparticles
#243ERYTHROID CELLS COMPRISING ARGINASE
#244ERYTHROID CELLS COMPRISING ARGININE DEIMINASE
#245Erythroid cells comprising phenylalanine ammonia lyase
#246ERYTHROID CELLS COMPRISING SERINE DEHYDRATASE
#247ERYTHROID CELLS COMPRISING LYSINE OXIDASE
#248SYNTHETIC MEMBRANE-RECEIVER COMPLEXES
#249Vaccine delivery systems using yeast cell wall particles
#250Enhanced loading of intact, bacterially derived vesicles with small molecule compounds
#251CELLS LABELLED WITH LIPID CONJUGATES AND METHODS OF USE THEREOF
#252Saposin lipoprotein particles and libraries from crude membranes
#253Tumoricidal and antimicrobial compositions and methods
#254Tumoricidal and antimicrobial composition
#255Tumoricidal and antimicrobial compositions and methods
#256THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS
#257Exosome-based therapeutics against neurodegenerative disorders
#258Synthetic membrane-receiver complexes
#259Hydrogel toxin-absorbing or binding nanoparticles
#260Tumoricidal and antimicrobial compositions and methods
#261Use of exosomes for the treatment of disease
#262Compositions and their use for controlling the nervous system in vivo
#263Exosome packaging of nucleic acids
#264Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
#265BIOSYNTHETIC MODULES
#266NANOPARTICLE TARGETED DRUG DELIVERY TO THE LUNGS USING EXTRA-TESTICULAR SERTOLI CELLS
#267Biomembrane, closed structure with biomembrane characteristics or cellular compartment derived from natural sources and/or self-assembly techniques, preparation method and applications thereof
#268Formulation comprising extracellular vesicles, method for producing the same, and uses thereof
#269Dendrimer-exosome hybrid nanoparticles as a delivery platform
#270Pharmaceutical kit comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor
#271THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS
#272Neural cell extracellular vesicles
#273Mesenchymal stem cell-derived exosomes and their uses
#274Bioactive delivery vehicles
#275Microvesicles derived from nucleated, mammalian cells and use thereof
#276METHODS FOR TARGETED IN VITRO AND IN VIVO DRUG DELIVERY TO MAMMALIAN CELLS VIA BACTERIALLY DERIVED INTACT MINICELLS
#277SYNTHETIC MEMBRANE-RECEIVER COMPLEXES
#278Engineered B lymphocytes and compositions having micro-RNA and methods for making and using them
#279Platelet membrane-coated drug delivery system
#280SYNTHETIC MEMBRANE-RECEIVER COMPLEXES
#281Synthetic membrane-receiver complexes
#282SYNTHETIC MEMBRANE-RECEIVER COMPLEXES
#283SYNTHETIC MEMBRANE-RECEIVER COMPLEXES
#284Serum Specific Drug Transport System
#285Device and method to treat esophageal disorders
#286Treating infection by a platelet-targeting microbe using nanoparticles
#287Detoxification using nanoparticles
#288Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
#289Synthetic membrane-receiver complexes
#290Novel Method for Producing Hollow Shells from Pollen Grains
#291Platelet-like proteo-microparticles and method of using such in drug delivery
#292Modulating antibacterial immunity via bacterial membrane-coated nanoparticles
#293Oncolytic virus formulation and preparation method thereof
#294Oncolytic herpes simplex virus infected cells
#295Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis
#296Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
#297Cell membrane-derived nanovesicles and use thereof
#298Synthetic membrane-receiver complexes
#299Extracellular vesicles for agent delivery
#300Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells